World-renowned expertise. Singularly focused.
Since Memorial Sloan Kettering Cancer Center (MSK) was established in New York City in 1884, our specialists have cared for adult and pediatric patients across the U.S. with uncompromising empathy and cutting-edge medicine. Our doctors treat more cancer patients in a single year than most do in a lifetime, resulting in some of the best — and most inspiring — health outcomes in the industry.
For 33 years running, U.S. News & World Report has honored MSK as one of the top 2 cancer hospitals in the nation. We’re proud of the “best hospital” distinction, but we’re even more proud of our exceptionally dedicated and compassionate staff.
MSK Direct was introduced in 2016 to make world-class cancer care accessible for employees and their loved ones, regardless of their job title or where they live. MSK Direct seeks to mitigate the traditional barriers to accessing high quality cancer care by providing individuals with the appropriate subspecialized expertise in the care setting that is best for them.
The program is supported at the highest levels of Memorial Sloan Kettering Cancer Center with full institutional backing of our executive leadership, board of directors, and subspecialized medical faculty.
We work collaboratively with employers, unions, benefits consultants, health plans, and third-party administrators to solve some of the toughest challenges to support employees and members across the nation who have or are concerned about cancer.
Sergio A. Giralt, MD
Chief Medical Officer, MSK Direct; Deputy Division Head, Division of Hematologic Malignancies; Melvin Berlin Family Chair in Multiple Myeloma
Bob T. Li, MD, PhD, MPH
Chief Scientific Officer, MSK Direct; Physician Ambassador to China and Asia-Pacific, Bobst International Center; Co-Director, Thoracic Liquid Biopsy Program
Executive Director, MSK Direct; Vice President New Markets
Vice President, Patient Access Program